RIPK3 and cancer: Therefore, we propose that NMR-specific loss-of-function mutations in the necroptosis regulators RIPK3 and MLKL may be one of the mechanisms underlying the attenuated tissue inflammatory response and remarkable cancer resistance of NMRs (Fig. 5e).